Cheaper eye drug could save sight for millions with diabetes
NCT ID NCT07663370
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines how well a biosimilar (a lower-cost copy) of the drug ranibizumab works for diabetic macular edema, a condition that causes vision loss in people with diabetes. Researchers will review medical records of 60 adults who received at least one injection of the biosimilar in routine care. They will measure changes in vision and retinal swelling to see if the biosimilar is a safe and effective option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ranibizumab biosimilar
What this could lead to
If effective, this could offer a more affordable treatment option for diabetic macular edema, potentially improving access to care.
What could go wrong
This is a small, retrospective study, so results may not apply to all patients. The biosimilar may not work as well as the original drug in some cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benha University
Banhā, Benha, 13111, Egypt